1. Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence;Chinen;Chem. Rev.,2015
2. B. Burtness, K.J. Harrington, R. Greil, D. Soulieres, M. Tahara, G. de Castro, Jr., A. Psyrri, N. Baste, P. Neupane, A. Bratland, T. Fuereder, B.G.M. Hughes, R. Mesia, N. Ngamphaiboon, T. Rordorf, W.Z. Wan Ishak, R.L. Hong, R. Gonzalez Mendoza, A. Roy, Y. Zhang, B. Gumuscu, J.D. Cheng, F. Jin, D. Rischin, Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study, Lancet 394(10212) (2019) 1915-1928.
3. Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis;Landgraf;Biomaterials,2020
4. Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy;Li;J. Control Rel.,2020
5. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells;Huanga;Cancer Lett.,2006